- 4
Christophe Klein
4
Documents
Identifiants chercheurs
- christophe-klein
- 0000-0001-8015-287X
Présentation
Publications
- 1
- 1
- 1
- 1
- 4
- 4
- 4
- 4
- 4
- 4
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 1
- 1
- 1
- 2
- 1
- 1
- 2
- 1
- 1
|
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancerNature Medicine, 2020, 26 (6), p. 919-931. ⟨10.1038/s41591-020-0882-8⟩
Article dans une revue
hal-03313676v1
|
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancerNature Medicine, 2020, 26 (6), pp.919-931. ⟨10.1038/s41591-020-0882-8⟩
Article dans une revue
hal-04210282v1
|
|
|
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeCell Research, 2019, 29 (10), pp.846-861. ⟨10.1038/s41422-019-0224-x⟩
Article dans une revue
hal-02461559v1
|
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumorsScience, 2018, 359 (6371), pp.91-97. ⟨10.1126/science.aan3706⟩
Article dans une revue
hal-02126484v1
|